WYC-210
CAS No. 2131803-93-3
WYC-210( —— )
Catalog No. M22099 CAS No. 2131803-93-3
WYC-210 is a retinoid compound,and with lower anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 238 | In Stock |
|
| 5MG | 216 | In Stock |
|
| 10MG | 315 | In Stock |
|
| 25MG | 508 | In Stock |
|
| 50MG | 686 | In Stock |
|
| 100MG | 930 | In Stock |
|
| 200MG | 1256 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWYC-210
-
NoteResearch use only, not for human use.
-
Brief DescriptionWYC-210 is a retinoid compound,and with lower anticancer activity.
-
DescriptionWYC-210 is a retinoid compound,and with lower anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2131803-93-3
-
Formula Weight340.4
-
Molecular FormulaC18H16N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)CCS(=O)c2ccc(cc12)C#Cc1ncc(cn1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
PF-04937319
PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
-
(3S)-3,7-dimethyloct...
(3S)-3,7-dimethyloctan-1-ol ((S)-3,7-dimethyl-1-octanol) can be used to synthesize liquid crystal compounds and nanoparticles.
-
Acifluorfen
Acifluorfen, a protoporphyrinogen oxidase (PROTOX) inhibitor herbicide, promotes the accumulation of protoporphyrin IX (PPIX), and induces tumors in the rodent liver. Acifluorfen causes strong photooxidative destruction of pigments and lipids in sensitive plant species.
Cart
sales@molnova.com